Literature DB >> 9274545

Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study.

I F Casson1, C A Clarke, C V Howard, O McKendrick, S Pennycook, P O Pharoah, M J Platt, M Stanisstreet, D van Velszen, S Walkinshaw.   

Abstract

OBJECTIVE: To monitor pregnancies in women with pre-existent insulin dependent diabetes for pregnancy loss, congenital malformations, and fetal growth in a geographically defined area of north west England.
DESIGN: Population cohort study.
SETTING: 10 maternity units in Cheshire, Lancashire, and Merseyside which had no regional guidelines for the management of pregnancy in diabetic women.
SUBJECTS: 462 pregnancies in 355 women with insulin dependent diabetes from the 10 centres over five years (1990-4 inclusive). MAIN OUTCOME MEASURES: Numbers and rates of miscarriages, stillbirths, and neonatal and postneonatal deaths; prevalence of congenital malformations; birth weight in relation to gestational age.
RESULTS: Among 462 pregnancies, 351 (76%) resulted in a liveborn infant, 78 (17%) aborted spontaneously, nine (2%) resulted in stillbirth, and 24 (5%) were terminated. Of the terminations, nine were for congenital malformation. The stillbirth rate was 25.0/1000 total births (95% confidence interval 8.9 to 41.1) compared with a population rate of 5.0/1000, and infant mortality was 19.9/1000 live births (5.3 to 34.6) compared with 6.8/1000. The prevalence of congenital malformations was 94.0/1000 live births (63.5 to 124.5) compared with 9.7/1000 in the general population. When corrected for gestational age, mean birth weight in the sample was 1.3 standard deviations greater than that of infants of non-diabetic mothers. Infants with congenital malformations weighed less than those without.
CONCLUSION: In an unselected population the infants of women with pre-existent insulin dependent diabetes mellitus have a 10-fold greater risk of a congenital malformation and a fivefold greater risk of being stillborn than infants in the general population. Further improvements in the management of pregnancy in diabetic women are needed if target of the St Vincent declaration of 1989 is to be met.

Entities:  

Mesh:

Year:  1997        PMID: 9274545      PMCID: PMC2127202          DOI: 10.1136/bmj.315.7103.275

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  107 in total

1.  Outcome of pregnancy in diabetic women in northeast England and in Norway, 1994-7.

Authors:  G Hawthorne; L M Irgens; R T Lie
Journal:  BMJ       Date:  2000-09-23

Review 2.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

3.  Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study.

Authors:  Rosemary Temple; Vivien Aldridge; Richard Greenwood; Philip Heyburn; Michael Sampson; Katharine Stanley
Journal:  BMJ       Date:  2002-11-30

Review 4.  Protecting the terminus: t-loops and telomere end-binding proteins.

Authors:  C Wei; M Price
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

5.  The confidential enquiry into maternal and child health (CEMACH).

Authors:  A M Weindling
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

6.  Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study.

Authors:  R Bell; S V Glinianaia; P W G Tennant; R W Bilous; J Rankin
Journal:  Diabetologia       Date:  2012-02-08       Impact factor: 10.122

7.  Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.

Authors:  Alice Panchaud; Valentin Rousson; Thierry Vial; Nathalie Bernard; David Baud; Emmanuelle Amar; Marco De Santis; Alessandra Pistelli; Anne Dautriche; Frederique Beau-Salinas; Matteo Cassina; Hannah Dunstan; Anneke Passier; Yusuf Cem Kaplan; Mine Kadioglu Duman; Eva Maňáková; Georgios Eleftheriou; Gil Klinger; Ursula Winterfeld; Laura E Rothuizen; Thierry Buclin; Chantal Csajka; Sonia Hernandez-Diaz
Journal:  Br J Clin Pharmacol       Date:  2018-01-14       Impact factor: 4.335

8.  A parent-of-origin analysis of paternal genetic variants and increased risk of conotruncal heart defects.

Authors:  Wendy N Nembhard; Xinyu Tang; Jingyun Li; Stewart L MacLeod; Joseph Levy; Gerald B Schaefer; Charlotte A Hobbs
Journal:  Am J Med Genet A       Date:  2018-02-05       Impact factor: 2.802

9.  Neuroinflammation-Related Encephalopathy in an Infant Born Preterm Following Exposure to Maternal Diabetic Ketoacidosis.

Authors:  David E Mandelbaum; Amanda Arsenault; Barbara S Stonestreet; Stefan Kostadinov; Suzanne M de la Monte
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

10.  Maternal diabetes in the rat impairs the formation of neural-crest derived cranial nerve ganglia in the offspring.

Authors:  J Cederberg; J J Picard; U J Eriksson
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.